[Changes in expression of PYCARD gene and its transcript variant mRNA in peripheral blood mononuclear cells of

Insights

PYCARD gene and protein expression are elevated in primary gout patients, indicating a significant role in regulating inflammatory responses. This finding highlights PYCARD as a potential biomarker for gout-related inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Gout is a form of inflammatory arthritis characterized by hyperuricemia and monosodium urate crystal deposition.
  • The inflammatory pathways involved in gout pathogenesis are complex and not fully understood.
  • PYCARD (PYRIN-PAAD-DAPIN domain containing) is a gene involved in inflammatory signaling.

Purpose of the Study:

  • To investigate the expression levels of the PYCARD gene and its mRNA variants in peripheral blood mononuclear cells (PBMCs) of patients with primary gout (PG).
  • To explore the role of PYCARD in the inflammatory processes associated with primary gout.

Main Methods:

  • Gene and mRNA expression of PYCARD and its variants were quantified using reverse transcription-polymerase chain reaction (RT-PCR).
  • Protein expression of PYCARD and NF-kappaB was assessed via Western blot.
  • Comparisons were made between patients with acute phase PG (APPG), non-acute phase PG (NAPPG), and healthy controls (HC).
  • Correlations with routine blood tests and uric acid levels were analyzed.

Main Results:

  • PYCARD gene and PYCARD-1,-2 mRNA expression were significantly higher in both APPG and NAPPG groups compared to HC.
  • Specific PYCARD transcript variants (2x and 2y mRNA) were elevated in NAPPG patients compared to HC and APPG.
  • PYCARD and NF-kappaB protein levels were significantly increased in PG patients versus HC.
  • PYCARD-2 mRNA expression positively correlated with granulocyte counts in the NAPPG group.

Conclusions:

  • Abnormal expression of PYCARD gene, its transcript variants, and PYCARD protein is observed in primary gout patients.
  • These findings suggest that PYCARD plays a crucial role in modulating the inflammatory response in primary gout.
  • PYCARD may serve as a potential therapeutic target or biomarker for gout.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
641
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
691
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
704
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.4K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K